|
Pascual-Figal D., Bayes-Genis A. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review. Frontiers in Cardiovascular Medicine. 2024. 11. 10.3389/fcvm.2024.1439696
AÑO: 2024; IF: 2.9
|
|
Wade U., Pascual-Figal D.A., Rabbani F., Ernst M., Albert A., Janssens I., Dierckxsens Y., Iqtadar S., Khokhar N.A., Kanwal A., Khan A. The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study. Nutrients. 18 April 2024. 16. 10.3390/nu16081204
AÑO: 2024; IF: 5.0
|
|
Pascual-Figal D.A., Hernández-Vicente A., Pastor-Pérez F., Martínez-Sellés M., Solé-González E., Alvarez-García J., García-Pavía P., Varela-Román A., Sánchez P.L., Delgado J.F., Noguera-Velasco J.A., Bayes-Genis A. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study. European Journal of Heart Failure. April 2024. 26:776-784. 10.1002/ejhf.3222
AÑO: 2024; IF: 10.8
|
|
de Miguel-Díez J., Núñez Villota J., Santos Pérez S., Manito Lorite N., Alcázar Navarrete B., Delgado Jiménez J.F., Soler-Cataluña J.J., Pascual Figal D., Sobradillo Ecenarro P., Gómez Doblas J.J. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease. Archivos de Bronconeumologia. April 2024. 60:226-237. 10.1016/j.arbres.2024.01.013
AÑO: 2024; IF: 9.2
|
|
Zuriaga M.A., Pascual-Figal D., Fuster J.J. Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations. European Heart Journal. 7 March 2024. 45:806-808. 10.1093/eurheartj/ehae052
AÑO: 2024; IF: 35.6
|